Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 14, 2025Medical Principles and PracticeOpen Access

The impact of pharmacist-led interventions on the treatment of COPD patients

View Full Paper
Ask AI
Bookmark
Share

Authors

KHKatalin HahnMarkusovszky Egyetemi OktatókórházMFMaria FlammParacelsus Medical UniversityBWBernhard WernlyGeneral Cardiology

Discussion

Loading...

Member takes

Overview

Systematic review highlights improvements in health outcomes for COPD patients through pharmacist-led interventions, indicating potential benefits.

Key Points

  • Pharmacist-led interventions can improve health outcomes in COPD patients, demonstrating significant benefits in eight of nine studies reported.
  • The review evaluates nine RCTs involving 2094 participants, focusing on medication adherence and educational interventions.
  • Education among COPD patients led to enhanced quality of life and better inhaler techniques, boosting overall treatment effectiveness.
  • Despite promising findings, the overall evidence quality is deemed low, highlighting the need for more rigorous research in this area.

Cite This Study

Hahn et al. (2025) studied this question.

synapsesocial.com/papers/689a02b6e6551bb0af8cc379https://doi.org/10.1159/000547390
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacist-Led Integrated Management for Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis2026
  2. 2Impact of Pharmacist-led Interventions on Medication Adherence and Inhalation Technique in Adult Patients with COPD and Asthma2024 · 2 citations
  3. 3The impact of pharmacist engagement on satisfaction with inhalers among patients with chronic obstructive pulmonary disease: a prospective interventional study2025
  4. 4Evaluation of a Tailored Multifaceted Pharmaceutical Care Intervention to Optimize Chronic Obstructive Pulmonary Disease Management: Protocol for a Cluster Randomized Controlled Trial2026 · 1 citations
  5. 54CPS-182 Description of a clinical pharmacist intervention focused on management of a chronic disease at hospital: the example of chronic obstructive pulmonary disease (COPD)2024